- Home
- SBI vs ANIX Comparison
SBI vs ANIX Comparison
Compare SBI & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBI
- ANIX
- Stock Information
- Founded
- SBI 1992
- ANIX 1982
- Country
- SBI United States
- ANIX United States
- Employees
- SBI N/A
- ANIX N/A
- Industry
- SBI Finance/Investors Services
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- SBI Finance
- ANIX Health Care
- Exchange
- SBI Nasdaq
- ANIX Nasdaq
- Market Cap
- SBI 111.5M
- ANIX 101.4M
- IPO Year
- SBI N/A
- ANIX 1987
- Fundamental
- Price
- SBI $8.02
- ANIX $3.06
- Analyst Decision
- SBI
- ANIX Strong Buy
- Analyst Count
- SBI 0
- ANIX 2
- Target Price
- SBI N/A
- ANIX $8.50
- AVG Volume (30 Days)
- SBI 39.5K
- ANIX 124.6K
- Earning Date
- SBI 01-01-0001
- ANIX 01-14-2025
- Dividend Yield
- SBI 4.52%
- ANIX N/A
- EPS Growth
- SBI N/A
- ANIX N/A
- EPS
- SBI N/A
- ANIX N/A
- Revenue
- SBI N/A
- ANIX N/A
- Revenue This Year
- SBI N/A
- ANIX N/A
- Revenue Next Year
- SBI N/A
- ANIX N/A
- P/E Ratio
- SBI N/A
- ANIX N/A
- Revenue Growth
- SBI N/A
- ANIX N/A
- 52 Week Low
- SBI $6.96
- ANIX $2.15
- 52 Week High
- SBI $8.00
- ANIX $5.13
- Technical
- Relative Strength Index (RSI)
- SBI 42.61
- ANIX 42.55
- Support Level
- SBI $8.01
- ANIX $3.02
- Resistance Level
- SBI $8.07
- ANIX $3.26
- Average True Range (ATR)
- SBI 0.06
- ANIX 0.26
- MACD
- SBI 0.00
- ANIX -0.05
- Stochastic Oscillator
- SBI 26.67
- ANIX 3.39
About SBI Western Asset Intermediate Muni Fund Inc
Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.